This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Antibody Engineering. Top assignees: Abgenix, Inc., Cell Genesys, Inc., Amgen Fremont Inc.. Active years: 1995-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2004)
- Darrien, CT (US) (2002 - 2007)
- Darien, CT (US) (1995 - 2014)
Company Filing History:
8 out of 32 
4 out of 78 
2 out of 78 
Years Active: 1995-2014
Areas of Expertise:
Title: Innovator Spotlight: Raju S. Kucherlapati
Introduction
Raju S. Kucherlapati, based in Darien, Connecticut, is a prominent inventor known for his significant contributions to biotechnology. With an impressive portfolio of 18 patents, his work primarily focuses on the engineering of transgenic non-human animals for medical advancements. His inventions have paved the way for innovations in antibody production, enhancing treatments for various diseases.
Latest Patents
Raju S. Kucherlapati's latest patents revolve around transgenic non-human animals that incorporate human immunoglobulin gene loci. These engineered animals possess plural variable (V and Vκ) gene regions, significantly enhancing the specificity and diversity of human antibodies they produce. The incorporation of these variable region genes not only improves antibody efficacy but also revitalizes B-cell development in these animals, resulting in a high abundance of mature B-cells that can secrete extremely high affinity antibodies. This groundbreaking work has implications for therapeutic applications, particularly in the field of immunology.
Career Highlights
Throughout his career, Raju has made notable contributions while working with leading biotech companies including Abgenix, Inc. and Cell Genesys, Inc. His innovative spirit and dedication have led to advancements within these organizations, driving research and development efforts in the realm of genetic engineering and antibody therapeutics.
Collaborations
In his journey, Raju has collaborated with esteemed colleagues including Aya Jakobovits and Daniel J. Capon. Their partnership showcases the dynamic interplay of ideas and expertise within the field, further underscoring Raju's commitment to collaborative innovation in biotechnology.
Conclusion
Raju S. Kucherlapati stands as a testament to innovation in the realm of biotechnology. His work on transgenic animals and the engineering of human antibody production not only highlights his expertise as an inventor but also his dedication to advancing medical science. With his continued contributions, the future looks promising for advancements in antibody therapies that will undoubtedly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile